PRODUCT FOCUS NIQUITIN BACKED BY £1.1 MILLION


MARKETING SPEND THIS SUMMER Perrigo, a leading provider of medicines and healthcare products, is supporting NiQuitin this summer with a £1.1 million marketing spend, a 15% increase in investment year-on-year


82% of smokers looking to quit or cut back agree that it will be hard to resist cravings and NiQuitin demonstrates how NRT can help them get over this barrier. It encourages quitters to use a ‘patch +1’ approach by combing NiQuitin Clear Patch for 24-hour control with NiQuitin Extra Fresh Mint gum to combat sudden cravings.


Kicking off in May, marketing activity will include TV advertising from 7th May to 9th July as well as out-of-home, digital display, social media and PPC.


Holly Turner, senior marketing director at Perrigo, said; “There are continued cuts to smoking cessation services by the NHS but smokers need support more than ever, with an astounding 97% who will fail to quit successfully relying on willpower alone. With this marketing drive, our aim is to educate quitters that combining a nicotine patch with an oral format such as NiQuitin Extra Fresh Mint gum will signifi cantly improve their chances of quitting.”


Perrigo has identifi ed that format is the most important driver to purchase after price, with patch and gum specifi ed by those intending to cut down or quit as the two preferred traditional NRT formats.


For more information on NiQuitin products, visit the brand website at www.niquitin.co.uk.


5793 Zeroderma quarter page advertorials v1.qxp_Zeroderma quarter page ad


Over £880,000 savings1 for NHS Scotland with Zeroderma


In need of employment advice or careers guidance?


WE CAN HELP


Specialist employment advice


On employment law, including discrimination, changes to terms and conditions and disciplinary or grievance procedures


Careers Coaching


Tailored support for those seeking help with their career


Pharmacist Support – the profession’s independent charity Call: 0808 168 2233 Visit: www.pharmacistsupport.org Email: info@pharmacistsupport.org


Pharmacist Support is a charitable company limited by guarantee registered in England & Wales, company no 9237609 & charity no 1158974


By changing from branded emollients to the cost effective Zeroderma emollient range, NHS Scotland could save over £880,000 a year and one Scottish Health Board could save over £142,000 p.a. without compromising on patient care.


The Zeroderma range offers products similar in formulation to around 60% of currently prescribed emollients and offers cost savings of up to 37%.


Many Health Boards and CCGs have adopted the Zeroderma range onto their formularies and cost savings are being made without compromising on patient care.


To find out how much your Health Board could save visit our QIPP and Emollients toolkit at qipp.zeroderma.co.uk, developed by Medicines Management teams it contains everything needed to implement product changes at practice level, as well as a guide to the savings your Health Board could make.


For further information or samples for patient evaluation, email: zeroderma@thorntonross.com or visit www.zeroderma.co.uk


Thornton & Ross, Linthwaite, Huddersfield. HD7 5QH


Phone: 01484 842217 | Web: www.zeroderma.co.uk 1. PCA data, October 2017


500g NEW


NEW pump


In this increasingly digital era, more people than ever regularly experience sore, tired eyes. Encouraging your customers to adopt a daily eye care regime, combining cleansing with protection and hydration, will help improve their eye health and comfort.


Step 1: Cleanse - Start your routine by cleansing your eyelids with Blephaclean®, Blephasol® or Blephagel®. Advise customers to massage eyelids gently using a vertical stroking motion


Step 2: Protect & Hydrate - Apply Thealoz® Duo eye drops for long lasting relief from the symptoms of dry eye. Added protection provided by the addition Trehalose.


All products are preservative-free, and suitable for ALL dry eye patients including contact lens wearers.


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48